Patents by Inventor Eric Jonathan Jacobsen

Eric Jonathan Jacobsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment
    Patent number: 9505765
    Abstract: 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds, pharmaceutically acceptable salts, solvates and pharmaceutical compositions of compounds embraced by Formula (I), provide a therapeutic benefit to subjects with disease conditions, especially cancer, wherein R1 and R2 are as defined in the detailed description.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: November 29, 2016
    Assignee: CONFLUENCE LIFE SCIENCES INC.
    Inventors: Eric Jonathan Jacobsen, John Robert Springer, James Robert Blinn, Balekudru Devadas
  • 4-ALKOXY/ARALKOXY-5-SUBSTITUTED-PYRROLOPYRIMIDINE COMPOUNDS AS TAK1 INHIBITORS IN DISEASE TREATMENT
    Publication number: 20150203499
    Abstract: The present disclosure provides 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds, pharmaceutically acceptable salts, solvates and pharmaceutical compositions of compounds embraced by Formula (I), providing a therapeutic benefit to subjects with disease conditions, especially cancer, wherein R1 and R2 are as defined in the detailed description.
    Type: Application
    Filed: July 26, 2013
    Publication date: July 23, 2015
    Inventors: Eric Jonathan Jacobsen, John Robert Springer, James Robert Blinn, Balekudru Devadas